Overview
Alvaro Tomas-Gomez practices practicing medicine in Barcelona, Spain.
His clinical expertise encompasses Pancreatic Ductal Adenocarcinoma and Basal Cell Skin Cancer.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Alvaro Tomas-Gomez
Is Alvaro Tomas-Gomez a top-rated expert for Pancreatic Ductal Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Alvaro Tomas-Gomez is classified as an Experienced expert for Pancreatic Ductal Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Alvaro Tomas-Gomez participate in research or clinical trials?
Yes. Alvaro Tomas-Gomez has published 11 articles and abstracts on conditions like Pancreatic Ductal Adenocarcinoma. You can view a list of Alvaro Tomas-Gomez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Basal Cell Skin CancerMr. Tomas-Gomez isExperienced. Learn about Basal Cell Skin Cancer.
- Pancreatic Ductal AdenocarcinomaMr. Tomas-Gomez isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.